261 related articles for article (PubMed ID: 19886552)
1. Cervical cancer screening programs in low-income communities. Experiences from Ecuador. Low cost detection of HPV infection in a developing country.
Cecchini G; Paganini G; D'Amico M; Cannone M; Bertuletti C; Barberis MC
Pathologica; 2009 Apr; 101(2):76-9. PubMed ID: 19886552
[TBL] [Abstract][Full Text] [Related]
2. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
[TBL] [Abstract][Full Text] [Related]
3. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions.
Coutlée F; Trottier H; Gagnon S; Koushik A; Richardson H; Roger M; Ferenczy AS; Franco EL
J Clin Virol; 2009 Jun; 45(2):96-9. PubMed ID: 19398216
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus testing for primary cervical cancer screening.
Grce M; Davies P
Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
[TBL] [Abstract][Full Text] [Related]
5. Molecular testing of human papillomavirus in cervical specimens.
Gazzaz FB
Saudi Med J; 2007 Dec; 28(12):1810-8. PubMed ID: 18060207
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
7. Season, sun, sex, and cervical cancer.
Hrushesky WJ; Sothern RB; Rietveld WJ; Du Quiton J; Boon ME
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1940-7. PubMed ID: 16103441
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology of HPV infections and cervical cancer in Apulia: a survey study and current data analysis].
Martinelli D; Chironna M; Tafuri S; Neve A; Caputi G; Prato R; Germinario C; Quarto M
Ann Ig; 2007; 19(6):499-508. PubMed ID: 18376570
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a colorimetric PCR system for the detection and typing of human papillomaviruses.
Chouhy D; Gil LB; Nocito AL; Wojdyla D; Ornella L; Cittadini J; Gardiol D; Giri AA
Int J Mol Med; 2006 Nov; 18(5):995-1003. PubMed ID: 17016633
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening in the early post vaccine era.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
[TBL] [Abstract][Full Text] [Related]
12. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
Dhaubhadel P; Vaidya A; Choudhary P
JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
[TBL] [Abstract][Full Text] [Related]
13. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
Papa D; Moore Simas TA; Reynolds M; Melnitsky H
J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
[TBL] [Abstract][Full Text] [Related]
14. Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia.
Gustavsson I; Juko-Pecirep I; Backlund I; Wilander E; Gyllensten U
J Clin Virol; 2009 Jun; 45(2):85-9. PubMed ID: 19451022
[TBL] [Abstract][Full Text] [Related]
15. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
[TBL] [Abstract][Full Text] [Related]
16. Why do we go on screening?
Marsan C
Pol J Pathol; 2005; 56(4):167-9. PubMed ID: 16477875
[TBL] [Abstract][Full Text] [Related]
17. New approaches to cervical cancer screening in Latin America and the Caribbean.
Herrero R; Ferreccio C; Salmerón J; Almonte M; Sánchez GI; Lazcano-Ponce E; Jerónimo J
Vaccine; 2008 Aug; 26 Suppl 11():L49-58. PubMed ID: 18945402
[TBL] [Abstract][Full Text] [Related]
18. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
Misra JS; Gupta HP; Das V
Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of self-collection of specimens for HPV DNA testing in an urban population.
Anhang R; Nelson JA; Telerant R; Chiasson MA; Wright TC
J Womens Health (Larchmt); 2005 Oct; 14(8):721-8. PubMed ID: 16232104
[TBL] [Abstract][Full Text] [Related]
20. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
Sankaranarayanan R; Budukh AM; Rajkumar R
Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]